Qian Zhan, Lei Zhang, Chenlei Wen, Ying Yang, Yangbing Jin, Dandan Ren, Zehui Zhang, Siyi Zou, Fanlu Li, Huaibo Sun, Jiabin Jin, Xiongxiong Lu, Junjie Xie, Dongfeng Cheng, Zhiwei Xu, Huan Chen, Beibei Mao, Jun Zhang, Jiancheng Wang, Xiaxing Deng, Chenghong Peng, Hongwei Li, Cen Jiang, Lin Lin, Henghui Zhang, Hao Chen, Baiyong Shen
BACKGROUND: Patients with resected pancreatic adenocarcinoma (PAAD) often experience short-term relapse and dismal survival, suggesting an urgent need to develop predictive and/or prognostic biomarkers for these populations. Given the potential associations of human leukocyte antigen class I (HLA-I) genotype with oncogenic mutational profile and immunotherapy efficacy, we aimed to assess whether differential HLA-I genotype could predict the postoperative outcomes in resected PAAD patients...
April 10, 2023: International Journal of Surgery